Counterpoint Mutual Funds’s Kyndryl KD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,711
Closed -$223K 349
2024
Q3
$223K Buy
+9,711
New +$237K 0.04% 259
2024
Q2
Sell
-25,234
Closed -$549K 261
2024
Q1
$549K Buy
+25,234
New +$537K 0.13% 35
2023
Q4
Sell
-15,535
Closed -$235K 198
2023
Q3
$235K Sell
15,535
-1,851
-11% -$27.5K 0.2% 33
2023
Q2
$231K Buy
17,386
+9,779
+129% +$132K 0.21% 31
2023
Q1
$112K Sell
7,607
-15,762
-67% -$224K 0.1% 116
2022
Q4
$260K Sell
23,369
-256
-1% -$2.58K 0.27% 19
2022
Q3
$195K Buy
+23,625
New +$246K 0.48% 63

Other funds holding KD

Counterpoint Mutual Funds's KD Position: Q4 2024 in Review

Counterpoint Mutual Funds sold out of Kyndryl (KD) in Q4 2024, closing a stake of 9,711 shares — an estimated $223K sold.

Counterpoint Mutual Funds first reported a position in KD in Q3 2022 and held it in 7 quarters. The position peaked at $549K in Q1 2024. 696 funds tracked by Wall St. Rank hold KD as of Q4 2024.

  • Counterpoint Mutual Funds reported no remaining Kyndryl position as of Q4 2024 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 9,711 Kyndryl shares in Q4 2024, an estimated $223K.
  • Counterpoint Mutual Funds first reported a position in Kyndryl in Q3 2022 and held it in 7 quarters.
  • Counterpoint Mutual Funds's Kyndryl position peaked at $549K in Q1 2024.
  • 696 funds tracked by Wall St. Rank held Kyndryl as of Q4 2024.

Based on Counterpoint Mutual Funds's 13F filing for Q4 2024, filed 10 Feb 2025.